PUMA BIOTECHNOLOGY, INC. (PBYI)
Latest PBYI Insider Trades
- Alan H. Auerbach - OfficerOpen-market sale$364K
Douglas M. Hunt - OfficerOpen-market sale$70K
About PUMA BIOTECHNOLOGY, INC. (PBYI)
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
- LOS ANGELES, CA
- 179
- 2012
- XNAS
https://www.pumabiotechnology.comSEC filings for PBYI on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 8 | 141,414 | $1.08M |
| Grant or award | 7 | 189,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
PBYI Insider Transactions (Form 4)
3221 Form 4 filings on record, the earliest from Jun 11, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Alan H. Auerbach - Officer | Open-market sale | Common Stock | 44,058 |
Recent PBYI Form 8-K Filings
4Recent PBYI Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - |
PBYI Insider Trading - FAQ
What is the latest insider trade for PBYI?
PUMA BIOTECHNOLOGY, INC. (PBYI) had 10 insider filings in the last 90 days, with the most recent on 2026-07-09. The full record for PBYI runs to 21 Form 4 filings, the earliest from 2025-06-11. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying PBYI stock?
No insider purchases of PBYI were filed in the last 90 days.
How many insiders are selling PBYI stock?
8 insider sales of PBYI were filed in the last 90 days, totaling $1.08M.
Where can I see PBYI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks PBYI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow PBYI insider buys?
Create a free InsiderAlpha account and press Watch on this page to add PBYI to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Alan H. Auerbach view on EDGAR
- - Douglas M. Hunt view on EDGAR
- - Maximo F. Nougues view on EDGAR
- - Troy Edward Wilson view on EDGAR
- - Brian M. Stuglik view on EDGAR
- - Adrian Senderowicz view on EDGAR
- - Michael Patrick Miller view on EDGAR
- - Jay M. Moyes view on EDGAR
- - Allison Dorval view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where PBYI's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track PBYI insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
